Literature DB >> 8221691

Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers.

C Y Yim1, N R Bastian, J C Smith, J B Hibbs, W E Samlowski.   

Abstract

The role of macrophages in the host immune response against cancers remains uncertain. Since nitric oxide synthesis represents a significant macrophage antitumor mechanism in vitro, we evaluated whether NO was synthesized during the immune response to growing murine skin cancers. NO synthesis was readily detectable in enzymatically dissociated tumors (RD-995 and LR-298) and was inhibited by N omega-monomethyl-L-arginine (MLA) and by macrophage depletion. Nitrosylation of iron-sulfur and heme complexes was observed in these tumors using electron paramagnetic resonance spectroscopy. NO production in the presence of increasing concentrations of MLA correlated inversely with tumor cell proliferation in vitro. To elucidate the role of NO during in vivo tumor progression, tumor-bearing mice were treated with continuous infusions of the nitric oxide synthase inhibitor MLA. MLA-treated mice demonstrated increased growth and delayed rejection of the highly antigenic UV radiation-induced regressor tumor LR-298. These experiments demonstrate that macrophage-derived NO synthesis can contribute to the antitumor immune response in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221691

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.

Authors:  Patricio López-Jaramillo; Melvin Y Rincón; Ronald G García; Sandra Y Silva; Erin Smith; Piyaporn Kampeerapappun; Carlos García; Daniel J Smith; Marcos López; Iván D Vélez
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

2.  Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1.

Authors:  S Pervin; R Singh; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Nitric oxide involvement in the toxicity of hydroxyguanidine in leukaemia HL60 cells.

Authors:  S A Everett; K A Smith; K B Patel; M F Dennis; M R Stratford; P Wardman
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 4.  Arginine de novo and nitric oxide production in disease states.

Authors:  Yvette C Luiking; Gabriella A M Ten Have; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

5.  Evaluation of the effects of nicorandil and its molecular precursor (without radical NO) on proliferation and apoptosis of 786-cell.

Authors:  Natália Aparecida de Paula; Andressa Megumi Niwa; Diogo Campos Vesenick; Carolina Panis; Rubens Cecchini; Angelo de Fátima; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

6.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death.

Authors:  V E Laubach; E G Shesely; O Smithies; P A Sherman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats.

Authors:  B L Buster; A C Weintrob; G C Townsend; W M Scheld
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Natural polyamine inhibits mouse skin inflammation and macrophage activation.

Authors:  Souren Paul; Sun Chul Kang
Journal:  Inflamm Res       Date:  2013-04-19       Impact factor: 4.575

Review 9.  Nitric oxide. Novel biology with clinical relevance.

Authors:  T R Billiar
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

10.  The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene.

Authors:  M R Dinapoli; C L Calderon; D M Lopez
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.